Integrated Pharmaceutical Care for Asthma-COPD Overlap Syndrome Patients
10.3870/j.issn.1004-0781.2018.03.011
- VernacularTitle:哮喘-慢性阻塞性肺疾病重叠综合征患者的全程化药学服务
- Author:
Zheng SONG
1
;
Cuicui ZHENG
;
Shuli XING
;
Shaowei SUN
;
Baoyuan LI
Author Information
1. 滨州医学院附属医院药学部
- Keywords:
Clinical pharmacist;
Pharmaceutical care,integrated;
Syndrome,overlap,asthma-COPD;
Medication educa-tion;
Medication compliance
- From:
Herald of Medicine
2018;37(3):319-322
- CountryChina
- Language:Chinese
-
Abstract:
Objective To apply intervention of integrated pharmaceutical care (IPC) for asthma-COPD overlap syn-drome patients,so as to reduce the side effects of drugs,enhance medication compliance,promote reasonable drug application,cut down the medical expenses in ACOS patients. Methods A total of 60 ACOS patients were randomly divided into IPC group (group A) (n=34) and contrast group(group B) (n=26).The patients in group A were given IPC measurements such as noso-comial guidance,classroom teaching,regular follow-up,life coaching and psychological advice.While the patients in group B were not given any intervention measures. Results In group A,patients' awareness rate of action and side-effects of drugs were ob-viously increased;Knowledges of inhalation preparation were greatly improved;the ratio of ADRs was significantly reduced;The FEV1 and the value added of FEV1 was dramatically improved.Furthermore,the differences showed statistical significance as com-pared with group B(P<0.05).Total medical costs and anti-bacterial drug costs per year were significantly lower in group A than group B. Conclusion IPC is beneficial to enhance drug compliance,promote reasonable drug application and bring down the medical expenses in ACOS patients.
